Prediction of Response to Irinotecan and Drug Toxicity Based on Pharmacogenomics Test: A Prospective Case Study in Advanced Colorectal Cancer

BACKGROUND: FOLFIRI regimen, which is composed of 5-FU, Leucovorin, and Irinotecan, is used in the first-line chemotherapy of metastatic colorectal cancer. Irinotecan life threatening toxicity is partly related to cytotoxic drug metabolite which is primarily inactivated by the UGT1A1 enzyme. The pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Emami, AH, Sadighi, S, Shirkoohi, R, Mohagheghi, MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747407/
https://www.ncbi.nlm.nih.gov/pubmed/29072417
http://dx.doi.org/10.22034/APJCP.2017.18.10.2803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747407/
https://www.ncbi.nlm.nih.gov/pubmed/29072417
http://dx.doi.org/10.22034/APJCP.2017.18.10.2803

Ejemplares similares